Zomedica Corp. (ZOM) Quick Liquidity

The visual representation of Zomedica Corp. (ZOM) prices available on the page is accompanied by data where the coefficient is 0.00. The business is currently focusing on the internal growth of a unified product portfolio, limiting the acquisition of IT projects. Process robotization via compact devices accelerates the delivery of diagnostics without laboratory involvement. Financial stability relies on the sale of Truforma equipment and the subsequent realization of profitable disposable test elements.

The high margins of Zomedica Corp. unique veterinary systems necessitate strict working capital management. This indicator assesses the company's ability to settle short-term debts using cash and accounts receivable, completely ignoring low-liquidity inventory. The stability of this metric minimizes credit risks, although excess cash may hinder expansion. By evaluating the current acid-test ratio, an investor determines the real financial stability of the business.